In this study, we demonstrated that the 5E5-based, humanized anti-MUC1 antibodies CIM301-1 and CIM301-8 are potent enhancers of NK cell activation and cytotoxicity against MUC1-Tn/STn positive tumor cells in vitro. This evidence concerns the gene EEF1A2 and neoplasm.